Parkinson's Disease: Genetics

Parkinson’s disease is a progressive neurodegenerative disorder that affects movement. This feed focuses on genetic screening approaches and genetic predispositions in Parkinson’s disease.

July 1, 2020

Dopamine Depletion induces Neuron-specific Alterations of GABAergic Transmission in the Mouse Striatum

The European Journal of Neuroscience
Ida Luisa BoccalaroLena Rubi
June 27, 2020
Case Report
Open Access

Intrafamilial phenotypic variation in spinocerebellar ataxia type 23

Cerebellum & Ataxias
Shunichi SatohKunihiro Yoshida
June 28, 2020
Preprint
Open Access

Association of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's Disease

MedRxiv : the Preprint Server for Health Sciences
P. SainiZ Gan-Or
June 28, 2020
Preprint
Open Access

Novel associations of BST1 and LAMP3 with rapid eye movement sleep behavior disorder

MedRxiv : the Preprint Server for Health Sciences
K. MuftiR. B. Postuma
July 1, 2020
Open Access

Appendectomy, Tonsillectomy and Parkinson's Disease Risk: A Swedish Register-Based Study

Frontiers in Neurology
Bojing LiuKarin Wirdefeldt
July 1, 2020

Genetic testing for Parkinson's disease: indication and practical implementation

Fortschritte der Neurologie-Psychiatrie
Lars TöngesStephan Klebe
July 2, 2020
Preprint

Non-allelic homologous recombination of Alu and LINE-1 elements generates somatic complexity in human genomes.

BioRxiv : the Preprint Server for Biology
G. PascarellaPiero Carninci
July 2, 2020

Enhancing the Activity of Glucocerebrosidase as a Treatment for Parkinson Disease

CNS Drugs
Elisa Menozzi, Anthony H V Schapira
July 1, 2020

The Impacts of Prominent Gene Polymorphisms in DNA Repair Enzymes on Parkinson's Disease

Neuroscience Letters
Nergis Selma AslanBensu Karahalil
June 27, 2020
Review
Open Access

MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes

International Journal of Molecular Sciences
Héctor Albert-GascóFrancisco E Olucha-Bordonau
July 1, 2020
Open Access

Accurate MS-based Rab10 phosphorylation stoichiometry determination as readout for LRRK2 activity in Parkinson's disease

Molecular & Cellular Proteomics : MCP
Ozge KarayelMatthias Mann
July 4, 2020
Review

Glial cells in Parkinson´s disease: protective or deleterious?

Cellular and Molecular Life Sciences : CMLS
Ana V DominguesFábio G Teixeira
July 1, 2020

Clinical and Pathological Phenotypes of LRP10 Variant Carriers with Dementia

Journal of Alzheimer's Disease : JAD
Leonie J M VergouwVincenzo Bonifati
July 3, 2020
Review
Open Access

LRRK2 Phosphorylation, More Than an Epiphenomenon

Frontiers in Neuroscience
Antoine MarchandJean-Marc Taymans
July 1, 2020

Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease

Acta Neuropathologica
S Bandres-CigaInternational Parkinson Disease Genomics Consortium

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/parkinsons-disease-genetics/aafce3ab-6d9e-42a4-9fdd-01b8c3f82139